Scarica l'app Stockscreener
9.46
2.94%
0.27
Pre-mercato:
9.85
0.39
+4.12%
Precedente Chiudi:
$9.19
Aprire:
$9.27
Volume 24 ore:
5.45M
Relative Volume:
1.09
Capitalizzazione di mercato:
$4.19B
Reddito:
$4.45B
Utile/perdita netta:
$205.00M
Rapporto P/E:
23.65
EPS:
0.4
Flusso di cassa netto:
$372.00M
1 W Prestazione:
+12.09%
1M Prestazione:
-11.51%
6M Prestazione:
-23.65%
1 anno Prestazione:
-28.93%
Intervallo 1D:
$9.14
$9.665
Intervallo di 1 settimana:
$8.33
$9.665
Portata 52W:
$8.02
$18.80
Elanco Animal Health Inc Stock (ELAN) Company Profile
Nome
Elanco Animal Health Inc
Settore
Telefono
877-352-6261
Indirizzo
2500 INNOVATION WAY, GREENFIELD
Confronta ELAN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
9.46 | 4.19B | 4.45B | 205.00M | 372.00M | 0.40 |
|
ZTS
Zoetis Inc
|
152.30 | 66.32B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.11 | 46.30B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.31 | 46.11B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
14.72 | 16.87B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
296.42 | 12.79B | 2.76B | 1.11B | 898.10M | 22.77 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-09 | Iniziato | UBS | Buy |
| 2024-12-02 | Iniziato | Leerink Partners | Market Perform |
| 2024-09-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-19 | Iniziato | Jefferies | Buy |
| 2023-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-04-20 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2022-08-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-07-21 | Downgrade | Goldman | Buy → Sell |
| 2022-07-12 | Iniziato | Piper Sandler | Neutral |
| 2021-11-18 | Iniziato | Morgan Stanley | Overweight |
| 2021-10-28 | Downgrade | Stifel | Buy → Hold |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-06-15 | Aggiornamento | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2021-05-11 | Aggiornamento | Gabelli & Co | Hold → Buy |
| 2021-04-15 | Iniziato | Stifel | Buy |
| 2021-03-22 | Downgrade | Gabelli & Co | Buy → Hold |
| 2021-02-26 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | Downgrade | Argus | Buy → Hold |
| 2020-11-09 | Downgrade | Barclays | Overweight → Underweight |
| 2020-08-20 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | Ripresa | Credit Suisse | Neutral |
| 2020-08-04 | Ripresa | Goldman | Buy |
| 2020-07-27 | Downgrade | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | Iniziato | Raymond James | Mkt Perform |
| 2019-12-19 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | Iniziato | Barclays | Overweight |
| 2019-08-26 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | Aggiornamento | UBS | Sell → Neutral |
| 2019-05-23 | Iniziato | Guggenheim | Neutral |
| 2019-03-18 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | Ripresa | Morgan Stanley | Equal-Weight |
| 2019-02-12 | Iniziato | William Blair | Mkt Perform |
| 2019-01-23 | Iniziato | UBS | Sell |
| 2019-01-15 | Iniziato | Argus | Buy |
| 2018-10-15 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Elanco Animal Health Inc Borsa (ELAN) Ultime notizie
Russell Investments Group Ltd. Decreases Stake in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Elanco Animal Health Incorporated (NYSE:ELAN) Shares Sold by Wells Fargo & Company MN - Defense World
Elanco Animal Health Inc [ELAN] Records 200-Day SMA of $12.48 - knoxdaily.com
COSM Stock Sees Surge of Approximately 15.01% in Last Five Days - knoxdaily.com
Elanco vs Zoetis stock: Sarat Sethi picks a side - TradingView
Animal Parasiticides Market Projected To Witness Substantial - openPR.com
Q1 EPS Estimate for Elanco Animal Health Reduced by Analyst - Defense World
Is Elanco Animal Health Inc. (NYSE:ELAN) the Best Cheap Stock to Buy Under $10? - Yahoo Finance
Are Elanco Animal Health Inc (ELAN) shares a good deal now? - uspostnews.com
Elanco Animal Health Inc Inc. (ELAN) Price Performance: The Role of Share Buybacks and Stock Splits - investchronicle.com
Veterinary Healthcare Market Generated Opportunities, Future - openPR.com
Why Should We Buy Elanco Animal Health Inc (ELAN) Stock? - Marketing Sentinel
Animal Internal Parasiticide Market Attractive Growth Proposition Seen in 2025: Zoetis, Elanco Animal Health, Virbac - openPR.com
Elanco price target lowered to $13 from $16 at BofA - Yahoo Finance
Market Insight: Elanco Animal Health Inc (ELAN)’s Notable Gain, Closing at 8.48 - DWinneX
Elanco's Breakthrough Treatment for Deadly Canine Parvovirus Has Saved Thousands of Puppies, Reaffirms Commitment to Increasing the Availability of Canine Parvovirus Monoclonal Antibody for Second Ann - GuruFocus
Elanco's Breakthrough Treatment for Deadly Canine Parvovirus Has Saved Thousands of Puppies, Reaffirms Commitment to Increasing the Availability of Canine Parvovirus Monoclonal Antibody for Second Annual National Parvo Awareness Day - marketscreener.com
What Does the Market Think About Elanco Animal Health? - Benzinga
This trade activity should not be overlooked: Elanco Animal Health Inc (ELAN) - Sete News
Elanco (ELAN) Target Price Cut by BofA, Buy Rating Maintained | ELAN Stock News - GuruFocus
BofA Securities Adjusts Elanco Animal Health Price Target to $13 From $16, Maintains Buy Rating - marketscreener.com
Pet Pharmaceuticals Market to Witness a Pronounce Growth during - openPR.com
Pet Medication Market: Revenue Growth to Stoke Up in Next Couple - openPR.com
Equine Healthcare Market Set to Witness Significant Growth by 2025-2032 | Merck, Bayer Health Care and Elanco - newstrail.com
Veterinary Dermatology Drugs Market Overall Study Report - openPR.com
Press Release Distribution & PR Platform - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Elanco Animal Health Incorporated (ELAN) Stockholders to Inquire about Securities Investigation - markets.businessinsider.com
Elanco Animal Health Incorporated (NYSE:ELAN) Receives Consensus Recommendation of “Hold” from Analysts - Defense World
Pet Health Market Hits New High | Major Giants Zoetis, IDEXX, Boehringer Ingelheim, Elanco, Vetoquinol - openPR.com
Elanco outlook revised to positive by S&P Global on reduced leverage - Investing.com South Africa
Middle East And Africa Animal Healthcare Market Generated - openPR.com
Elanco Animal Health Incorporated (NYSE:ELAN) Shares Sold by Alliancebernstein L.P. - Defense World
LPL Financial LLC Raises Holdings in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Stockholders to Connect - markets.businessinsider.com
Veterinary Medicine Market to Witness Remarkable Growth with Ceva, Zoetis, Elanco, Chanelle Pharma Group - openPR.com
Elanco (ELAN) Sees Price Target Cut by Morgan Stanley to $10 | ELAN Stock News - GuruFocus
US FDA approves Elanco's treatment for parasitic infections in dogs - AOL.com
Elanco Animal Health (NYSE:ELAN) Given New $13.00 Price Target at Stifel Nicolaus - Defense World
Stifel Adjusts Elanco (ELAN) Price Target, Maintains Buy Rating - GuruFocus
Franklin Resources Inc. Has $1.87 Million Stock Position in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - markets.businessinsider.com
‘Let the bad news travel as fast as the good news’: 5 questions for Elanco Animal Health’s Jeff Simmons - Semafor
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Stockholders to Learn More About the Investigation - markets.businessinsider.com
Elanco Animal Health (ELAN) Soars 12.6%: Is Further Upside Left in the Stock? - Yahoo Finance
Companion Animal Vaccine Marketto Register for Rapid Growth, - openPR.com
Elanco Confirms Date and Conference Call for First Quarter 2025 Financial Results Announcement | ELAN Stock News - GuruFocus
Elanco Confirms Date and Conference Call for First Quarter 2025 Financial Results Announcement - Nasdaq
Pets External Medicine Market Still Has Room To Grow: Zoetis, Elanco, Merck Animal Health, Bayer Animal Health - openPR.com
American Century Companies Inc. Acquires 2,280 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Elanco enters research agreement to address CKD in cats and explore lifespan extension in pets - DVM360
Veterinary Oncology Market Is Booming Worldwide 2025-2032 | - openPR.com
Elanco Animal Health Inc Azioni (ELAN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.92%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):